Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 16;18(2):e0281676. doi: 10.1371/journal.pone.0281676

Gadolinium-enhanced MRI visualizing backflow at increasing intra-renal pressure in a porcine model

Søren Kissow Lildal 1,*, Esben Søvsø Szocska Hansen 2, Christoffer Laustsen 2, Rikke Nørregaard 3, Lotte Bonde Bertelsen 2,3, Kirsten Madsen 4, Camilla W Rasmussen 2, Palle Jörn Sloth Osther 5,6, Helene Jung 5,6
Editor: Kartikeya Rajdev7
PMCID: PMC9934347  PMID: 36795705

Abstract

Introduction

Intrarenal backflow (IRB) is known to occur at increased intrarenal pressure (IRP). Irrigation during ureteroscopy increases IRP. Complications such as sepsis is more frequent after prolonged high-pressure ureteroscopy. We evaluated a new method to document and visualize intrarenal backflow as a function of IRP and time in a pig model.

Methods

Studies were performed on five female pigs. A ureteral catheter was placed in the renal pelvis and connected to a Gadolinium/ saline solution 3 ml/L for irrigation. An occlusion balloon-catheter was left inflated at the uretero-pelvic junction and connected to a pressure monitor. Irrigation was successively regulated to maintain steady IRP levels at 10, 20, 30, 40 and 50 mmHg. MRI of the kidneys was performed at 5-minute intervals. PCR and immunoassay analyses were executed on the harvested kidneys to detect potential changes in inflammatory markers.

Results

MRI showed backflow of Gadolinium into the kidney cortex in all cases. The mean time to first visual damage was 15 minutes and the mean registered pressure at first visual damage was 21 mmHg. On the final MRI the mean percentage of IRB affected kidney was 66% after irrigation with a mean maximum pressure of 43 mmHg for a mean duration of 70 minutes. Immunoassay analyses showed increased MCP-1 mRNA expression in the treated kidneys compared to contralateral control kidneys.

Conclusions

Gadolinium enhanced MRI provided detailed information about IRB that has not previously been documented. IRB occurs at even very low pressures, and these findings are in conflict with the general consensus that keeping IRP below 30–35 mmHg eliminates the risk of post-operative infection and sepsis. Moreover, the level of IRB was documented to be a function of both IRP and time. The results of this study emphasize the importance of keeping IRP and OR time low during ureteroscopy.

Introduction

Indications for ureteroscopy have expanded dramatically during recent years, and although ureteroscopy in general is considered a safe procedure, serious complications and even deaths do occur, and these are most often related to sepsis [1]. To understand this, we must focus on how ureteroscopy may push upper urinary tract physiology to pathophysiology [3, 10]. When advancing a ureteroscope to the upper urinary tract and using saline irrigation, which is necessary for vision, the intrarenal pressure will increase significantly [5, 6], and when exceeding certain thresholds, intrarenal backflow may occur: backflow of urine and irrigation fluid to the renal tubules and the venous system. We have studied intrarenal pressure during ureteroscopy quite extensively during recent years [3, 6, 10]; however, our understanding on the relation between intrarenal pressure (IRP) and intrarenal backflow (IRB), which is the likely event immediately before sepsis, is still deficient; and the objective of this study was to approach this knowledge gap. The specific aim was to evaluate and visualize IRB dynamically as a function of intrarenal pressure and time using MRI in a porcine model with a Gadolinium tracer in the irrigation fluid.

Materials and methods

Experimental animals

The animal protocol was approved by The National Animal Experiments Inspectorate (Copenhagen, Denmark). Studies were performed on 5 anaesthetized female pigs weighing 45 kg (Påskehøjgård, Ølsted, Denmark). The pigs were fed a standard diet during breeding. Before the study they had access to water but were fasting 12 hours prior to anaesthesia.

After premedication with azaperone (4mg/kg) and midazolam (4 mg/kg), anaesthesia was induced by propofol (4–20 mg/kg) and maintained with sevoflurane (1.2 MAC) and fentanyl (0.03 mg/kg/h). The pigs were orotracheally intubated and mechanically ventilated (GE Healthcare S5 Avance). Hydration was maintained by administration of saline (9 g/l sodium chloride; 10 ml/kg/h) at a temperature of 37°C through an ear vein.

A cystoscope was inserted through the urethra into the bladder. A ureteral catheter (Selectip®, Bard Medical, Covington, USA) was placed in the distal part of the ureter and a retrograde pyelography was performed to visualize the anatomy of the upper urinary tract. A guide wire (Sensor®, Boston Scientific, Marlborough, MA, USA) was placed via the ureteral catheter, through the ureter, to the renal pelvis, and the cystoscope was removed.

Over the guide wire, and under fluoroscopic guidance, a dual lumen catheter (Cook Medical, Bloomington, IN, USA) was inserted to the distal ureter and through this a second guidewire was inserted to the renal pelvis and the catheter was removed. Over the first guidewire a regular ureteral catheter was placed in the middle of the renal pelvis and over the second guidewire an occlusion balloon catheter (Boston Scientific, Marlborough, MA, USA) was inserted and the balloon was inflated just above the level of the uretero-pelvic junction. The correct placement of both catheters was confirmed by contrast fluoroscopic pyelography (Fig 1) and the flow function through both catheters was confirmed by gravity-mediated infusion into the ureteral catheter and free outflow through the occlusion balloon catheter. Both catheters were fixed outside the urinary tract with adhesive tape to the skin of the pig to ensure a fixed position. A urethral catheter was placed in the urinary bladder to ensure drainage of urine and irrigation fluid during the testing period.

Fig 1. Pyelography.

Fig 1

Placement of ureteral catheter and balloon catheter for occlusion, irrigation and pressure measurement confirmed by fluoroscopic pyelography.

The animal was then placed in the MR scanner with the ureteral catheter connected to an irrigation pump and the occlusion catheter to a pressure monitor. A baseline MR scan was done before initiation of irrigation and the baseline intraluminal pressure was registered.

A Gadolinium/saline solution 3 mL/L was mounted in the irrigation pump and irrigation was initiated to evaluate the resulting intraluminal pressure. The flow was continuously regulated to maintain steady intraluminal pressure levels starting with a pressure of 10 mmHg and through the study raising it to 20, 30, 40 and 50 mmHg. At each of these pressure levels, MR scans were performed with 5-minute intervals.

After finishing the MR scan series, the animals were brought back to the OR where both kidneys were removed in vivo, to obtain tissue samples from the upper pole, middle region and lower pole. Samples were preserved in formaldehyde for histopathological evaluation and snap frozen in liquid nitrogen and stored at -80°C for ELISA and PCR analysis. Finally, the pigs were euthanized under anaesthesia, with 20 ml of pentobarbital, 200mg/ml.

MR

After initial scout images to locate the position and orientation of the kidneys, for each pressure level, T1-maps of the kidneys were obtained. The images were acquired using a single-shot inversion recovery spin echo sequence in an oblique coronal plane. Seven slices were acquired covering almost the entire kidneys. T1 mapping was performed using inversion time (TI from 200 ms to 1800 ms). The slices thickness was 5 mm, and acquired pixel size was 3 x 3 mm. Repetition time (TR) was 5 secs and echo time (TE) was 20 ms.

Prior to analysis, the images were motion corrected by doing cross correlation of the image gradient maps for the different inversion times. T1-maps were calculated by fitting the pixel signal to the equation describing the signal at different TI times: S(TI) = S_0 |(1-2e^(-TI⁄T_1) |. The development of T1 with increasing pressure was assessed by placing ROI’s in different segments of the kidneys, and plotting T1 as function of pressure.

NGAL and KIM-1 ELISA measurements

ELISA for Neutrophil gelatinase-associated lipocalin (pig NGAL ELISA kit 044, BioPorto) and Kidney Injury Molecule-1 (pig KIM-1/HAVCR1 ELISA kit abx255516, Abbexa) was performed according to the manufacturer´s instructions. In Brief, Kidney tissue was snap-frozen in liquid nitrogen. Thereafter, tissue was homogenized and centrifuged and ELISA performed on the resultant supernatant.

RNA extraction, cDNA synthesis and quantitative PCR

Total RNA from cortical tissue was isolated using the NucleoSpin RNA II mini kit according to the manufacturers protocol (Macherey Nagel, Nordrhein-Westfalen, Germany). The RNA concentration was measured with spectrophotometry and samples were stored at -80˚C until use.

cDNA synthesis was performed using 0.5 μg RNA using the RevertAid First Strand Synthesis Kit (Thermo Fisher Scientific, MA, USA). For qPCR, 100 ng of cDNA served as a template for the PCR amplification using the Brilliant SYBR® Green qPCR master Mix according to the manufacturer’s instruction (Thermo Fisher Scientific, MA, USA) by using an Aria Mx3000P qPCR system (Agilent Technologies, Santa Clara, Ca). Samples and the standards were prepared in duplicate in 96-well plates and PCR was accomplished for 40 cycles consisting of denaturation for 30s at 95°C followed by annealing and polymerization at 60°C for 1 min. Emitted fluorescence was detected during the annealing/extention step in each cycle. Specificity was ensured by post-run melting curve analysis and reaction products were separated on agarose gels and imaged. GAPDH was used as housekeeping gene. Primer sequences are shown in Table 1.

Table 1. PCR primer sequences.

Primers used for qPCR.

Forward primer Reverse primer
TNF-alpha 5’- GGC TGC CTT GGT TCA GAT GT-3 5’-CAG GTG GGA GCA ACC TAC AGT T -3’
IL-1beta 5’-GAT GAC ACG CCC ACC CTG-3’ 5’-CAA ATC GCT TCT CCA TGT CCC-3’
COX-2 5’- CAA AAC CGT ATT GCT GCT GA -3’ 5’- CAA AAC CGT ATT GCT GCT GA -3’
MCP1 5’-ACT TGG GCA CAT TGC TTT CCT-3’ 5’-TTT TGT GTT CAC CAT CCT TGC A-3’
IL-6 5’-AGA CAA AGC CAC CAC CCC TAA-3’ 5’-CTC GTT CTG TGA CTG CAG CTT ATC-3’
GAPDH 5’-AGC AAT GCC TCC TGT ACC AC-3’ 5’-AAG CAG GGA TGA TGT TCT GG-3’

Histology

Kidney tissue was cut in coronal slices though the tip of a papilla and embedded in paraffin. For histological evaluation of kidney morphology, 4 μm thick tissue slices were cut on a microtome and mounted on microscope glass slides (Superfrost). All slides were deparaffinized, and tissue visualized by hematoxylin eosin (H&E) and periodic acid-shiff (PAS) staining. Kidney morphology was evaluated by standard light microscopy (Olympus).

Statistics

Biochemical and qPCR was analysed using a two-way mixed-effects model taking into account the multiple samples from the same kidneys and the same animal. Normality was assessed by QQ-plots. All statistical analyses were performed in GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA).

Results

MR

The experiment was successfully completed in all 5 animals, and MR clearly showed backflow of Gadolinium into the kidney cortex in all cases. The measured mean baseline pressure before initiation of irrigation was 9.6 mmHg (range: 5–13). Under controlled irrigation the pressure was gradually increased while repeating MR scans until a maximum pressure of approximately 50 mmHg was reached. The mean maximum pressure recorded for all cases at termination of irrigation was however only 43 mmHg due to inability to increase the pressure to more than 20 mmHg in one of the animals, which was probably because of compromised occlusion by the balloon catheter and thus leakage of irrigation fluid down the ureter. We did however in this case find MR changes in the kidney cortex similar to all other cases regarding the degree of backflow and development over time.

Uniformly for all cases, MR showed early signs of intrarenal backflow into the cortex of the kidneys clearly visualised as pyramid shaped changes first appearing in the upper and lower poles (Fig 2). Subsequently more and more similar shaped changes appeared in all other regions until large areas (mean 66% of the renal cortex, Figs 3 and 4) were affected at the end MR scan (Fig 5).

Fig 2. First visual changes.

Fig 2

First MR-scan for each of the 5 animals with visual changes appearing as dark areas (arrows). In animal no. 4 the study was performed on the right kidney due to catheter placement failure on the left side. 1: 22 min—25 mmHg 2: 5 min– 20 mmHg 3: 25 min– 22 mmHg 4: 20 min– 22 mmHg 5: 5 min– 16 mmHg.

Fig 3. Time series MR.

Fig 3

Time series of MR-scans in 1 animal from baseline (0 mins) to end scan (80 mins) showing increased T1 values with rising intraluminal pressure (10 mmhg– 50 mmHg) in the right kidney. 0 min—10 mmHg 20 min– 22 mmHg 40 min– 31 mmHg 60 min– 40 mmHg 80 min– 50 mmHg.

Fig 4. Whole cortex changes.

Fig 4

Fraction of whole cortex T1 changes as a function of time from baseline scan to 60 mins. scan for all 5 experimental animals. The curves are ended at 60 mins. as some of the experiments were ended at this time point. At 60 minutes a mean of 66% of the cortex was affected by intrarenal backflow.

Fig 5. Final MR scan.

Fig 5

Final MR-scan for the 5 animals showing widespread T1 changes as dark areas (arrows) due to increased intraluminal pressure in the treated kidneys. Time range 60–80 mins; pressure range 20–54 mmHg. In animal no. 4 the study was performed on the right kidney due to ureteral catheter placement failure on the left side. 1: 72 min—51 mmHg 2: 60 min– 20 mmHg 3: 80 min– 40 mmHg 4: 80 min– 50 mmHg 5: 60 min– 54 mmHg.

The mean time to first visual renal cortex changes was 15 minutes (range: 5–25 min) and more importantly the mean registered pressure at first visual change was only 21 mmHg (range: 16–25 mmHg).

In order to relate these results to a clinical situation we combined these two factors and calculated the accumulated pressure applied within the pelvis over time (mmHg x min). The mean total time from irrigation start to finish was 70 minutes (range 60–80 min) and the mean total accumulated pressure was 405 mmHg x minutes. The mean accumulated pressure at first visual damage was 70 mmHg x minutes (Fig 6).

Fig 6. T1 vs accumulated pelvis pressure.

Fig 6

The development of T1 with increasing accumulated pressure (mmHg x min) was assessed by placing ROI’s in different segments of the kidneys, and plotting T1 as function of time x pressure. Left vertical axis: T1; right vertical axis: accumulated pressure; horizontal axis: time. Each graph represents the treated kidney of each of the 5 animals. Cortex remote: visibly non-affected area; cortex 1–4: visibly affected cortical areas; renal pelvis; medulla and dorsal muscle ROIs depicted by lines. Pressure at a given time depicted by colour filled area under the curve. T1 values in affected areas decrease as a function of increasing pressure/time.

On the final MR scan of all cases the areas showing backflow by changes in T1 values were mapped and a fraction of affected/total kidney tissue was calculated. The consequent mean percentage of affected kidney was 66% (range 43.2% - 79.6%) after irrigation with a mean maximum pressure of 43 mmHg for a mean duration of 70 minutes.

Histopathology

The obtained samples from the upper, mid and lower part of the kidneys were evaluated by light microscopy. No histological signs of inflammation or acute tissue damage could be found.

PCR and immunoassay

Cortical tissue samples were divided into upper, mid and lower pole of the kidney. NGAL and KIM-1 protein levels were analyzed by ELISA analysis and no significant difference was observed between the ureteroscopically treated kidney and the contralateral control kidney. mRNA expression of the inflammation markers COX-2, IL-6, IL-1-beta, MCP 1 and TNF-alfa was evaluated by QPCR analysis. Data showed increased MCP-1 mRNA expression in the treated kidneys compared to contralateral control kidneys. There was no significant change in mRNA expression of the other inflammation markers (Fig 7).

Fig 7. PCR and ELISA results.

Fig 7

KIM-1 was not associated with any statical significant difference between the upper (U), mid (M) and lower (P) pole of the kidney (p = 0.044), nor between the ureteroscopically treated and the contralateral kidney (p = 0.18). No statistical significant difference was found between the kidney regions and between the contralateral and the ureteroscopic treated kidney respectively for NGAL (p = 0.38, p = 0.45), COX-2 (p = 0.75,p = 0.75), IL-1beta (p = 0.52,p = 0.42), IL-6 (p = 0.33,p = 0.80) and TNF-alpha (p = 0.65,p = 0.79). MCP-1 was on the other hand found to be statistical significant upregulated in the ureteroscopic treated (p = 0.04), while no regional difference was found (p = 0.55). Y-axis units: KIM-1 and NGAL: ng/ml. COX-2, IL-1beta, IL-6, MCP-1 and TNF-alfa: mRNA expression (qPCR marker/GAPDH ratio).

Discussion

Miniaturization of ureteroscopic instruments combined with increasingly potent laser technology for the treatment of kidney stones may require forced, high-pressure irrigation to clear stone dust, blood and debris. As a consequence, IRP rises unequivocally during ureterorenoscopic procedures. The physiological IRP in the un-obstructed human kidney is 0–10 mmHg [2]. Human and porcine renal anatomy and physiology are comparable, and several studies have documented IRP in the porcine and human kidney to be at the same level, which was confirmed in the present study [2, 3]. IRP during ureteroscopic treatment of kidney stones can reach 3–400 mm Hg [4, 5]. Previous studies have suggested IRB to occur at approximately 30 mmHg [6, 7]. Increased IRP and IRB constitutes a major predisposing factor for postoperative complications such as sepsis and hemorrhage [811] and the per-operative IRP level and irrigation volume appear to be independent risk factors for the development of systemic inflammatory response syndrome (SIRS).

In recent years there has been increasing focus on IRP during endourological procedures and the potential harmful postoperative effects of IRB. As neither the IRP nor the level of IRB is normally determined in clinical settings, the pathophysiological and pathoanatomical changes that may follow ureteroscopy are not fully understood.

In this study we aimed to visually document IRB as a function of increasing IRP and time, using Gadolinium tracer in the irrigation fluid followed by dynamic MR scans. The setup allowed MR visualization of the gradual backflow beyond the limits of the kidneys at increasing IRP in a porcine model mimicking a clinical situation.

IRB has in former studies been documented using light microscopy, x-ray, ink-irrigation or simple measurement of fluid absorption [6, 1214]. Visualization of IRB by dynamic MR using Gadolinium [15] contrast agents and T1-mapping MRI represents a new methodology, providing more information of the level and the nature of IRB [16]. Gd-enhanced MRI is a well-established clinical tool for a wide range of indications and as such could be easily translated to clinical usage. It should be noted that Gd contrast agents are contraindicated for intravenous use in patients with chronic kidney disease (CKD) but there is no evidence for kidney damage in endoluminal Gd contrast administration [15, 17, 18].

Using this new method, we were able to determine the mean percentage of affected kidney tissue according to IRP and time exposure. The T1 mapping revealed a mean percentage of affected kidney of 66% at a mean IRP of 43 mmHg. We find it remarkable that over half of the kidney tissue was affected by IRB at this relatively low pressure, which is considered to be a realistic pressure level in a clinical setting during ureteroscopy. The MR scans clearly visualized the increasing degree of IRB, not only as a function of increasing IRP, but interestingly also as a function of time at steady IRP as shown in the graph of animal no. 2 in Figs 6 and 8, where the pressure rose to 20 mmHg immediately and remained at this level. Moreover, MR visualization of the renal parenchyma showed in detail at which pressure level the individual renal pyramids were influenced by IRB, uniformly showing early signs of intrarenal backflow into the cortex of the kidneys clearly visualised as pyramid shaped changes first appearing in the upper and lower pole. Subsequently, similar shaped changes appeared in all other regions until large areas were affected at the end of MR scan. This is in accordance with previous findings by other authors using different methodology [12].

Fig 8. T1 vs pelvis pressure.

Fig 8

The development of T1 with increasing pressure was assessed by placing ROI’s in different segments of the treated kidneys, and plotting T1 as function of time/pressure. Left vertical axis: T1; right vertical axis: pressure; horizontal axis: time. Each graph represents the treated kidney of each of the 5 animals. Cortex remote: visibly non-affected area; cortex 1–4: visibly affected areas; renal pelvis; medulla and dorsal muscle ROIs depicted by lines. Pressure at a given time depicted by colour filled area under the curve. T1 values in affected areas decrease as a function of increasing pressure/time.

In this study, IRB was investigated at pressure levels of 10–50 mm Hg within 70 minutes of continuous irrigation. The pressure levels and time settings were chosen based on former human studies determining the average IRP during ureteroscopic procedures and on the basis of an assumption that the maximum duration of a ureteroscopic procedure is 70–90 minutes [4, 5, 19]. IRP may be much higher than 50 mmHg as documented by for example Jung and Osther and Wilson [5, 4], but IRB was evident in all kidneys within the range of 16–25 mmHg, and consequently we found no indication to examine higher pressure levels in this primary investigation.

Most remarkable, IRB was evidenced at an IRP of only 16 mmHg, range 16–25 mm Hg. To our knowledge, IRB at such low pressures has not been documented earlier. IRB was observed at a mean IRP of 21 mmHg. Recent studies propose IRB to take place at 30–35 mm Hg [6, 13, 20]. Stenberg et al. proposed that the extent of IRB depends on the condition of the kidney: In a hydronephrotic kidney and in kidneys with thin renal cortex, IRB seem to occur at lower IRPs compared to a normal kidney [12]. The kidneys in our study were normal with no signs of hydronephrosis or renal atrophy. The use of Gadolinium MR scan probably identifies signs of IRB and changes in the renal parenchyma in a more accurate way compared to former investigation methods, which may explain our results.

Clinical studies concluding that placement of a ureteral access sheath (UAS) may solve the problems associated with increased IRP by increasing the outflow from the renal pelvis assume that IRB takes place at 30–35 mm Hg. However, IRP during ureteroscopy with an inserted UAS often exceed 25–30 mm Hg [21, 22] and therefore UAS may not always prevent IRB and concomitant postoperative complications. Therefore, these observations raise thoughts about further technological and clinical improvements to secure low-pressure ureteroscopy.

In order to create a measure for accumulated ureteroscopy-induced pressure impact (AUPI) on the kidney, we calculated the accumulated pressure applied within the renal pelvis over time. In a clinical experimental setting, AUPI may be used to compare the accumulated impact (= pressure x time) on the kidney with clinical outcomes such as post-operative infection, fever, sepsis, hospitalization time and biomarker measures. According to other studies, not only the level of IRP, but also operation length has an impact on post-operative outcome [2325]. We found a mean total time from irrigation start to finish of 70 minutes (range 60–80 min) and a mean total accumulated pressure of 405 mmHg x minutes. The mean AUPI at first visual damage was 70 mmHg x minutes. In future studies, this measure may be used to correlate pressure and OR time and observe changes in IRB accordingly. Until now it is not known if short-lasting, extensive pressure increments exert more damage than long-lasting, moderate pressure. The present study set-up may contribute to answering this question.

The design and setup of this experimental pilot study possess limitations.

In one of the pigs, it was not feasible to increase the pressure to more than 20 mmHg, probably due to leakage of urine from the renal pelvis to the bladder. The pigs varied with respect to ureteral anatomy and diameter, which may explain the inconsistency in pressure recordings. However, the main aim of the study was to obtain a clinical relevant IRP and observe correspondent incidents in the kidney and surroundings at given pressure measurements. It is concluded that these conditions were met in this study design.

The study does not provide information about the potential clinical consequences of the observed IRB. Histological examinations showed no signs of acute tissue damage in the renal parenchyma, which however was not surprising, as parenchymal changes are expected to occur days to weeks after exposure to high pressure according to previous studies [14, 26]. In a future study design, evaluation of renal parenchymal pathology 2–4 weeks after high-pressure exposure would be valuable, which will require post-procedural survival of the pigs.

Biomarker analyses indicate early and mild inflammation. This is in line with the fact that this study is acute and aimed to examine the lower threshold for intrarenal backflow, which was found to be at a very low intrarenal pressure. For the relatively low pressures applied in this study it would not be expected to find severe tissue damage either histopathologically or by analysis of inflammatory markers. It does however show that MR is very sensitive in detecting potentially damaged regions that may deteriorate over time. The current results also indicate that future studies on intraluminal pressure should include tissue sample analysis for inflammation in order to examine if higher IRB would elicit a more profound biomarker response or not. Depending on the results of such studies it may also be deducted if IRB in fact is a physiological mechanism that in itself limits the degree of IRP and thus also potential tissue damage.

The most important conclusion of this study is that IRB takes place at even very low pressures, which may alter the assumption that keeping IRP below 30–35 mmHg eliminates the risk of post-operative infection and sepsis. Moreover, the level of IRB was documented to be a function of both IRP and time. The results of our study certainly provide an opportunity to further clarify both short-term and long-term effects on renal function due to the pressure increments in endoscopic procedures The results of this study emphasize the importance of keeping IRP low, although more investigations evaluating the relationship between IRP, OR time and IRB are essential. Hence, further technological improvements and clinical advancements are desirable to secure even better clinical outcomes for patients undergoing ureteroscopic procedures.

Supporting information

S1 Table. Histopathology results.

Hematoxylin eosin (H&E) and periodic acid-shiff (PAS) staining of kidney tissue samples. Morphology was evaluated by standard light microscopy.

(DOCX)

Acknowledgments

The authors thank Gitte Kall and Gitte Skou for expert technical laboratory assistance.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Cindolo L, Castellan P, Scoffone CM, Cracco CM, Celia A, Paccaduscio A, et al. (2016) Mortality and flexible ureteroscopy: analysis of six cases. World journal of urology 34 (3):305–310. doi: 10.1007/s00345-015-1642-0 [DOI] [PubMed] [Google Scholar]
  • 2.JC D (1980) Aspects of Renal Pelvic Function. University of Copenhagen, Copenhagen [Google Scholar]
  • 3.Kiil F (1953) Pressure recordings in the upper urinary tract. Scandinavian journal of clinical and laboratory investigation 5 (4):383–384. doi: 10.3109/00365515309094217 [DOI] [PubMed] [Google Scholar]
  • 4.Jung H, Osther PJ (2015) Intraluminal pressure profiles during flexible ureterorenoscopy. SpringerPlus 4:373. doi: 10.1186/s40064-015-1114-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wilson WT PG (1990) Intrarenal pressures generated during flexible deflectable ureterorenoscopy. Journal of endourology / Endourological Society 4:135–142 [Google Scholar]
  • 6.Thomsen HS (1984) Pyelorenal backflow. Clinical and experimental investigations. Radiologic, nuclear, medical and pathoanatomic studies. Danish medical bulletin 31 (6):438–457 [PubMed] [Google Scholar]
  • 7.Thomsen HS, Dorph S, Larsen S, Talner LB (1983) Intrarenal backflow and renal perfusion during increased intrapelvic pressure in excised porcine kidneys. Acta radiologica: diagnosis 24 (4):327–336 doi: 10.1177/028418518302400410 [DOI] [PubMed] [Google Scholar]
  • 8.Zhong W, Leto G, Wang L, Zeng G (2015) Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors. Journal of endourology / Endourological Society 29 (1):25–28. doi: 10.1089/end.2014.0409 [DOI] [PubMed] [Google Scholar]
  • 9.Mykoniatis I, Sarafidis P, Memmos D, Anastasiadis A, Dimitriadis G, Hatzichristou D (2020) Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes. Clinical kidney journal 13 (4):531–541. doi: 10.1093/ckj/sfaa020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bhojani N, Miller LE, Bhattacharyya S, Cutone B, Chew BH (2021) Risk Factors for Urosepsis After Ureteroscopy for Stone Disease: A Systematic Review with Meta-Analysis. Journal of endourology / Endourological Society 35 (7):991–1000. doi: 10.1089/end.2020.1133 [DOI] [PubMed] [Google Scholar]
  • 11.Farag M, Timm B, Davis N, Wong LM, Bolton DM, Jack GS (2020) Pressurized-Bag Irrigation Versus Hand-Operated Irrigation Pumps During Ureteroscopic Laser Lithotripsy: Comparison of Infectious Complications. Journal of endourology / Endourological Society 34 (9):914–918. doi: 10.1089/end.2020.0148 [DOI] [PubMed] [Google Scholar]
  • 12.Stenberg A, Bohman SO, Morsing P, Müller-Suur C, Olsen L, Persson AE (1988) Back-leak of pelvic urine to the bloodstream. Acta physiologica Scandinavica 134 (2):223–234. doi: 10.1111/j.1748-1716.1988.tb08483.x [DOI] [PubMed] [Google Scholar]
  • 13.Thomsen HS, Larsen S (1983) Intrarenal backflow during retrograde pyelography with graded intrapelvic pressure. A pathoanatomic study. Acta pathologica, microbiologica, et immunologica Scandinavica Section A, Pathology 91 (4):245–252. doi: 10.1111/j.1699-0463.1983.tb02753.x [DOI] [PubMed] [Google Scholar]
  • 14.Schwalb DM, Eshghi M, Davidian M, Franco I (1993) Morphological and physiological changes in the urinary tract associated with ureteral dilation and ureteropyeloscopy: an experimental study. The Journal of urology 149 (6):1576–1585 doi: 10.1016/s0022-5347(17)36456-x [DOI] [PubMed] [Google Scholar]
  • 15.Dekkers IA, de Boer A, Sharma K, Cox EF, Lamb HJ, Buckley DL, et al. (2020) Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI. Magma (New York, NY) 33 (1):163–176. doi: 10.1007/s10334-019-00797-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, et al. (2021) Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology 298 (1):28–35. doi: 10.1148/radiol.2020202903 [DOI] [PubMed] [Google Scholar]
  • 17.Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, et al. (2018) Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Canadian Association of Radiologists journal = Journal l’Association canadienne des radiologistes 69 (2):136–150. doi: 10.1016/j.carj.2017.11.002 [DOI] [PubMed] [Google Scholar]
  • 18.Schultz J, Andersen A, Gade IL, Ringgaard S, Kjaergaard B, Nielsen-Kudsk JE (2018) A porcine in-vivo model of acute pulmonary embolism. Pulmonary circulation 8 (1):2045893217738217. doi: 10.1177/2045893217738217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lildal SK, Andreassen KH, Baard J, Brehmer M, Bultitude M, Eriksson Y, et al. (2020) Consultation on kidney stones, Copenhagen 2019: aspects of intracorporeal lithotripsy in flexible ureterorenoscopy. World journal of urology. doi: 10.1007/s00345-020-03481-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Osther PJ, Pedersen KV, Lildal SK, Pless MS, Andreassen KH, Osther SS, et al. (2016) Pathophysiological aspects of ureterorenoscopic management of upper urinary tract calculi. Current opinion in urology 26 (1):63–69. doi: 10.1097/MOU.0000000000000235 [DOI] [PubMed] [Google Scholar]
  • 21.De Coninck V, Keller EX, Rodríguez-Monsalve M, Audouin M, Doizi S, Traxer O (2018) Systematic review of ureteral access sheaths: facts and myths. BJU international 122 (6):959–969. doi: 10.1111/bju.14389 [DOI] [PubMed] [Google Scholar]
  • 22.Wong VK, Aminoltejari K, Almutairi K, Lange D, Chew BH (2020) Controversies associated with ureteral access sheath placement during ureteroscopy. Investigative and clinical urology 61 (5):455–463. doi: 10.4111/icu.20200278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Whitehurst LA, Somani BK (2017) Perirenal Hematoma After Ureteroscopy: A Systematic Review. Journal of endourology / Endourological Society 31 (5):438–445. doi: 10.1089/end.2016.0832 [DOI] [PubMed] [Google Scholar]
  • 24.Uchida Y, Takazawa R, Kitayama S, Tsujii T (2018) Predictive risk factors for systemic inflammatory response syndrome following ureteroscopic laser lithotripsy. Urolithiasis 46 (4):375–381. doi: 10.1007/s00240-017-1000-3 [DOI] [PubMed] [Google Scholar]
  • 25.Fan S, Gong B, Hao Z, Zhang L, Zhou J, Zhang Y, et al. (2015) Risk factors of infectious complications following flexible ureteroscope with a holmium laser: a retrospective study. International journal of clinical and experimental medicine 8 (7):11252–11259 [PMC free article] [PubMed] [Google Scholar]
  • 26.Boddy SA, Nimmon CC, Jones S, Ramsay JW, Britton KE, Levison DA, et al. (1989) Irrigation and acute ureteric dilatation—as for ureteroscopy. British journal of urology 63 (1):11–13 doi: 10.1111/j.1464-410x.1989.tb05114.x [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Kartikeya Rajdev

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

31 Oct 2022

PONE-D-22-27295GADOLINIUM-ENHANCED MRI VISUALIZING BACKFLOW AT INCREASING INTRA-RENAL PRESSURE IN A PORCINE MODELPLOS ONE

Dear Dr. Lildal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kartikeya Rajdev, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in your Competing Interests section:  

"No"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

4. Please amend your manuscript to include your abstract after the title page

5. Please ensure that you refer to Figures 6 and 8 in your text as, if accepted, production will need this reference to link the reader to the figure.

6. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 in your text; if accepted, production will need this reference to link the reader to the Table.

7. Please include a copy of Table 2 which you refer to in your text on page 3. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study examines the possibility of rare but significant side effect of sepsis with ureteroscopy. The pathophysiology is well explained in the abstract summarized in the following lines " When advancing a ureteroscope to the upper urinary tract and using saline irrigation,

which is necessary for vision, the intrarenal pressure will increase significantly and

when exceeding certain thresholds, intrarenal backflow may occur: backflow of urine and

irrigation fluid to the renal tubules and the venous system."

Reviewer #2: Your study definitely sets stage for further studies to identify safest way to perform urological procedure. Questions like- (1) if short-lasting, extensive pressure increments exert more damage than long-lasting, moderate pressure. (2) MR cab be sensitive in detecting potentially damaged regions that may deteriorate over time but it possibly only imaging changes without any significant clinical outcomes.

I have some questions regarding your study-

You had mentioned no histological signs of inflammation or acute tissue damage could be found and then mentioned it takes some time 2-4weeks to show histopathological signs later in article, Is this time for histopathological changes specific for humans or other animals?

Data showed increased MCP-1 mRNA expression in the treated kidneys compared to contralateral control kidneys. There was no significant change in mRNA expression of the other inflammation markers. It further suggests there may not be significant inflammatory changes in tissue itself and MRI findings are just related to gadolinium contrast entering tissue but may not have actual pathological changes.

IRP during ureteroscopic treatment of kidney stones can reach 3-400 mm Hg[4,5]. Are there any studies measuring IRP with obstructing stones causing hydronephrosis before doing any procedures.

Using this new method, we were able to determine the mean percentage of affected kidney tissue according to IRP and time exposure. The T1 mapping revealed a mean percentage of affected kidney of 66% at a mean IRP of 43 mmHg. Have you monitored reversibility if we stop procedure at certain time and after few minutes/hours MRI shows no residual IRB?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Simhachalam Gurugubelli

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 16;18(2):e0281676. doi: 10.1371/journal.pone.0281676.r002

Author response to Decision Letter 0


2 Jan 2023

Response to reviewers

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Answer: The manuscript has been changed according to the requirements.

2. Thank you for stating the following in your Competing Interests section:

"No"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

This information should be included in your cover letter; we will change the online submission form on your behalf.

Answer: The statement: ”The authors have declared that no competing interests exist.” has been added to the cover letter.

3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Answer: The phrase: ”data not shown” has been removed, as it is not a core part of the study. The histopathology section now merely states that no histological findings were present.

4. Please amend your manuscript to include your abstract after the title page

Answer: The abstract has been added to the manuscript.

5. Please ensure that you refer to Figures 6 and 8 in your text as, if accepted, production will need this reference to link the reader to the figure.

Answer: References have been added to figs 6 and 8.

6. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 in your text; if accepted, production will need this reference to link the reader to the Table.

Answer: Referral to Figure 2 has been changed to Figure 1. There is no Figure 2. This was a typing error.

7. Please include a copy of Table 2 which you refer to in your text on page 3.

Answer: Referral to Figure 2 has been changed to Figure 1. There is no Figure 2. This was a typing error.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study examines the possibility of rare but significant side effect of sepsis with ureteroscopy. The pathophysiology is well explained in the abstract summarized in the following lines " When advancing a ureteroscope to the upper urinary tract and using saline irrigation,

which is necessary for vision, the intrarenal pressure will increase significantly and

when exceeding certain thresholds, intrarenal backflow may occur: backflow of urine and

irrigation fluid to the renal tubules and the venous system."

Answer: Thank you for the comment.

Reviewer #2: Your study definitely sets stage for further studies to identify safest way to perform urological procedure. Questions like- (1) if short-lasting, extensive pressure increments exert more damage than long-lasting, moderate pressure. (2) MR cab be sensitive in detecting potentially damaged regions that may deteriorate over time but it possibly only imaging changes without any significant clinical outcomes.

Answer: Thank you for the interesting comments.

(1) Indeed this is an interesting question. In this study we aimed to show what happens in a setting with relatively low pressure in order to find a threshold for intrarenal backflow. Another study to perform would be a ”worst case scenario” study, similarly performed but with increasing pressures.

(2) We do not know if this MR detected IRB leads to clinically significant damage. This is merely a preliminary study to detect the lower limit of IRB. We do however have plans to perform further studies regarding the potential damages caused by backflow with other MR modalities able to show changes in kidney physiology/metabolism in the future.

I have some questions regarding your study-

You had mentioned no histological signs of inflammation or acute tissue damage could be found and then mentioned it takes some time 2-4weeks to show histopathological signs later in article, Is this time for histopathological changes specific for humans or other animals

Answer: The studies referred to were both done in animal settings with minipigs. Histopathological studies on kidney damages following ureteroscopy are not possible to do in humans as you have to remove the kidney to examine the tissue. We suggested a future study similar to the present study, also in pigs surviving for 2-4 weeks before removing the kidney for examination. Thus we do not know for sure if these earlier findings are specific for pigs but in general pig upper urinary tracts are considered to be very similar to human upper urinary tracts.

Data showed increased MCP-1 mRNA expression in the treated kidneys compared to contralateral control kidneys. There was no significant change in mRNA expression of the other inflammation markers. It further suggests there may not be significant inflammatory changes in tissue itself and MRI findings are just related to gadolinium contrast entering tissue but may not have actual pathological changes.

Answer: This is correct. In this study we can only deduct that the threshold for IRB is very low in vivo as we set out to. We aimed for finding this threshold and thus performed the study in a low pressure setting. The finding of no serious damages is therefore reasonable and we did not expect to find serious damages at least not in short term. The study aimed to simulate what happens generally in human procedures and we do not see very often that kidney function deteriorates significantly shortly after surgery. To find out if it is just imaging changes or if there is a clinically significant damage to kidney physiology we are performing further studies with other MR protocols.

IRP during ureteroscopic treatment of kidney stones can reach 3-400 mm Hg[4,5]. Are there any studies measuring IRP with obstructing stones causing hydronephrosis before doing any procedures.

Answer: Not to our knowledge, and this is also a very difficult study to do. But there are animal studies on partial and complete obstruction showing deterioration of kidney function om MR.

Using this new method, we were able to determine the mean percentage of affected kidney tissue according to IRP and time exposure. The T1 mapping revealed a mean percentage of affected kidney of 66% at a mean IRP of 43 mmHg. Have you monitored reversibility if we stop procedure at certain time and after few minutes/hours MRI shows no residual IRB?

Answer: We have not yet done this. We would expect that the Gadolinium contrast would be washed out and thus the MR changes would be reversible in our opinion. We do not know the time frame for this. We are not planning to examine this using Gadolinium but we are in the proces of examining it using other MR protocols more specific for kidney physiology.

Decision Letter 1

Kartikeya Rajdev

30 Jan 2023

Gadolinium-enhanced MRI visualizing backflow at increasing intra-renal pressure in a porcine model

PONE-D-22-27295R1

Dear Dr. Lildal,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kartikeya Rajdev, MD

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Overall well written study, it sets a stage for further studies for safe way to perform procedure. Overall data is presented in thorough manner. With limitations of study, you can assume MRI can detect acute damage to kidney at more sensitive way and at earlier time.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

Acceptance letter

Kartikeya Rajdev

5 Feb 2023

PONE-D-22-27295R1

Gadolinium-enhanced MRI visualizing backflow at increasing intra-renal pressure in a porcine model

Dear Dr. Lildal:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kartikeya Rajdev

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Histopathology results.

    Hematoxylin eosin (H&E) and periodic acid-shiff (PAS) staining of kidney tissue samples. Morphology was evaluated by standard light microscopy.

    (DOCX)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES